Kirurgisk behandling af midt og lav rectumcancer

TY - JOUR

T1 - Kirurgisk behandling af midt og lav rectumcancer

AU - Bjørn, Maya Xania

AU - Perdawood, Sharaf Karim

PY - 2017/9/4

Y1 - 2017/9/4

N2 - Total mesorectal excision (TME) is standard treatment of mid- and low rectal cancer and has evolved with minimally invasive surgery. Laparoscopic TME has proven to be technically challenging, and recent randomized controlled studies fail to prove it oncologically superior to open TME. Robotic-assisted TME may overcome the technical difficulties and shows comparable oncological results, yet it is associated with significant additional costs. Transanal TME is a promising method which seems to overcome the technical and financial issues of the other techniques, without compromising the short-term oncological results.

AB - Total mesorectal excision (TME) is standard treatment of mid- and low rectal cancer and has evolved with minimally invasive surgery. Laparoscopic TME has proven to be technically challenging, and recent randomized controlled studies fail to prove it oncologically superior to open TME. Robotic-assisted TME may overcome the technical difficulties and shows comparable oncological results, yet it is associated with significant additional costs. Transanal TME is a promising method which seems to overcome the technical and financial issues of the other techniques, without compromising the short-term oncological results.

KW - English Abstract

KW - Journal Article

M3 - Tidsskriftartikel

C2 - 28553924

SN - 0041-5782

VL - 179

SP - 1577

EP - 1580

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 18

ER -